Dolantin

PreclinicalSmall molecule

MMedipol University

Dolantin is one of 4 small molecule programs targeting Labor Analgesia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Labor AnalgesiaCompleted

Labor AnalgesiaPreclinical

Completed

Competition

Competitive Landscape

4 competitors in Labor Analgesia

#DrugCompanyPhaseTrials

Iheezo

BB. Braun Medical Inc.

Approved

1 2

Chirocaine

PPurdue Pharma LP

Preclinical

4 3

Hyperbaric Bupivacaine

TTanta University

Preclinical

1 4

Dolantin

MMedipol University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Labor Analgesia1 trial

Epidural Tap in Labor Analgesia FOR LABOR ANALGESIA

Completed·MMedipol University·N/A·NCT05499234·70 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Dolantin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Dolantin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Dolantin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Medipol University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMedipol University

Dolantin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Labor Analgesia1 trial

References

Drug Info

Quick Facts

Related News